Delivery Order SPE2DB22D3501-SPE2DB23FVQ90
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565978330 - Norepinephrine 8 mg/250 ml-D5W 250ml. The firm-fixed-price delivery order, valued at $1,686.36, has an ultimate completion date of October 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of norepinephrine 8 mg/250 ml-D5W 250ml. The contract, valued at $2,796.06, is a firm fixed-price delivery order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,017,672 units of the drug Norepinephrine 8 mg/250 mL-D5W 250 mL. The contract has a ceiling value of $1,009.65 and is a firm fixed-price delivery order with a period of performance through January 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of norepinephrine 4 ml 10s. The contract is a delivery order valued at $1,318.38 with a firm fixed price and an ultimate completion date of January 8, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,759.11, is for the delivery of a 250 mL bag of norepinephrine 8 mg/250 mL in D5W. This is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 19, 2024. The $1,795.93 firm fixed-price delivery order is for the supply of norepinephrine 8 mg/250 ml-D5W 250 ml, a critical pharmaceutical product. The contract has an ultimate completion date of March 20, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NOREPINEPHRINE 8 MG/250 ML-D5W 250ML. The contract has a ceiling value of $5,766.39 and a performance period through July 2, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is for the delivery of various pharmaceutical products and medical supplies, including norepinephrine 4ml vials, to support military and veteran healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $92,358.84, with a firm fixed-price pricing type and an ultimate completion...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $1,606.80 firm fixed price contract is for the supply of 4564414423 - Norepinephrine 8 mg/250 ml-D5W 250 ml, with a completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Norepinephrine 4 mg/4 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,578.89, and has a completion date of May 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, worth up to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FVQ90Delivery Order
This federal contract award, with ID SPE2DB22D3501|SPE2DB23FVQ90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560896338 - Norepinephrine 8 mg/250 ml-D5W 250 ml, a pharmaceutical product. The contract has a ceiling value of $1,624.18 and is a Firm Fixed Price Delivery Order type, with a period of performance through May 11, 2023. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/10/23 |